ARCHIVES

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

Ganz Awarded Professor Of Survivorship By Komen.

January 28, 2000

Also in this 8-page issue: Intel Chairman Andrew Grove slams NCI director and cancer program for “wishful dreams” and “chemo speeches,” recommends moratorium on funding for cancer research.

May 14, 2004

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005

RFA On Breast Cancer Low Fat Diet Available

November 25, 1983

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010